Skip to content
★ Sign in to follow
KB
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 01 Jun 2007 for ABIOMED INC.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Karim Benali: trading record in brief

All filings by Karim Benali on record concern Abiomed Inc. Between 31 March 2006 and 30 May 2007, the trades on record add up to 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 1 June 2007 came the latest disclosure, a share grant in Abiomed Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Karim Benali

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    Chief Medical OfficerExecutivesAbiomed Inc
    0SEC
    6,000 shares0Common Stock, $.01 par valueSEC:0001179110-07-011907:0
  • ◆
    Chief Medical OfficerExecutivesAbiomed Inc
    2,392 USD0SEC
    206 shares@ US$11.61Common Stock, $.01 par valueSEC:0001179110-07-007052:0
  • ◆
    Chief Medical OfficerExecutivesAbiomed Inc
    2,402 USD0SEC
    219 shares@ US$10.97Common Stock, $.01 par valueSEC:0001179110-06-019994:0
  • ◆
    VP Product DevelopmentExecutivesAbiomed Inc
    2,403 USD0SEC
    284 shares@ US$8.46Common Stock, $.01 par valueSEC:0001179110-06-007596:0

4 of 4 declarations